类器官Y-27632 dihydrochloride

类器官Y-27632 dihydrochloride

参考价: ¥3750

具体成交价以合同协议为准
2024-11-06 18:03:43
461
属性:
供货周期:现货;
>
规格:
50mg;
>
产品属性
供货周期
现货
关闭
类器官Y-27632 dihydrochloride

参考价: ¥3750

50mg 3750元 50 mg可售
x
普迈精医科技(北京)有限公司

普迈精医科技(北京)有限公司

顶级会员4
收藏

组合推荐相似产品

产品简介

类器官Y-27632 dihydrochloride
类器官(Organoids)是指将成体干细胞或多能干细胞在体外三维培养形成的具有一定空间结构的组织类似物。类器官在组织结构、细胞类型、自我更新能力和功能等方面与来源组织高度一致,从而在发育生物学、疾病造模、精准医学、药物研发、基因和细胞疗法、感染和免疫以及再生医学等生物医学的多个领域展现出*的优势。

详细介绍

类器官Y-27632 dihydrochloride


类器官(Organoids)是指将成体干细胞或多能干细胞在体外三维培养形成的具有一定空间结构的组织类似物。类器官在组织结构、细胞类型、自我更新能力和功能等方面与来源组织高度一致,从而在发育生物学、疾病造模、精准医学、药物研发、基因和细胞疗法、感染和免疫以及再生医学等生物医学的多个领域展现出*的优势。

产品介绍
DESCRIPTION

Background
Y-27632 dihydrochloride is an orally active, ATP-competitive inhibitor of ROCK-I and ROCK-II, with Kis of 220 and 300 nM, respectively. Y-27632 dihydrochloride attenuates Doxorubicin-induced apoptosis of human cardiac stem cells. Y-27632 also suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells. Y-27632 dihydrochloride primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation[1][2][3][4][5].

技术参数

M. W t320.26
FormulaC14H23Cl2N3O
CAS No129830-38-2                                                
StoragePowder-20 °C3 years
In solvent-80°C6 months
-20 °C1 month
SolubilityDMSO    33.33 mg/mL(104.07 mM; Need ultrasonic)

H2O100 mg/mL(312.25 mM; Need ultrasonic)

BIOLOGICAL ALTIVITY
In Vitro   
Y-27632 inhibits the ROCK family of kinases 100 times more potently than other kinases including protein kinase C, cAMP-dependent kinase and myosin light chain kinase. Y-27632 prolongs the lag time and delays the appearance of BrdU-labeled cells in a concentration-dependent manner, delays of about 1 and 4 h are noticed in the Swiss 3T3 cells treated with 10 and 100 μM Y-27632, respectively[1].
Y-27632 promotes neuronal differentiation of adipose tissue-derived stem cells (ADSCs). Compared to 1.0 and 2.5 μM Y-27632 induced groups, percentages of neuroal-like cells achieved a peak in the 5.0 μM Y-27632 induced group[2].

In Vivo  
Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of myoclonic jerks when compare with saline group. Y-27632 (5 and 10 mg/kg) significantly prolongs the onset time of clonic convulsions when compare with saline group[3].
Treatment with Dimethylnitrosamine (DMN) causes a significant decrease in rat body and liver weight (DMN-S group) compared with control animals (S-S group). Oral Y27632 (30 mg/kg) essentially prevents this DMN-induced rat body and liver weight loss (DMN-Y group)[4].

类器官Y-27632 dihydrochloride

上一篇:内皮细胞培养基的优点与使用注意事项 下一篇:MesenPlify™ 干细胞扩增培养基技术资料(第四期)
热线电话 在线询价
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :